NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1730275439 M.D.
Verify on CMS → Allan Fleming, M.D.
Medical Oncology Physician in Kansas City, Kansas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
177
Medicare Part D claims · 43 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
33%
generic claims · 67% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.9/100
▲ 8 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Allan Fleming, M.D. reported a CMS MIPS final score of 91.9/100 - above the 83.5 national average - and filed 177 Medicare Part D claims in 2024.
- 91.9/100
- MIPS score · +8 vs avg
- 177
- Part D claims, 2024
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Allan Fleming, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1730275439), first enumerated 10/04/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 177 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1730275439 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1730275439
- ENUM-LEGACY 2006
- TAX-NARROW 4,028
- MIPS-ABOVE 91.9/100
- RX-LIGHT 177
- BOOK-THIN 29 in Kansas
- PHOTO-FINISH Shalina Gupta-Burt,… · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Fleming · this p…
Fleming · this provider
91.9 MIPS pts
- Ana Velazquez, M…
Ana Velazquez, MD MSC
91.9 MIPS pts
- Shalina Gupta-Bu…
Shalina Gupta-Burt, M.D.
91.9 MIPS pts
- Jayasree Rao, M.…
Jayasree Rao, M.D.
91.9 MIPS pts
- Terence Friedlan…
Terence Friedlander, MS
91.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Allan Fleming, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
92 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Allan Fleming, M.D. sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Allan Fleming, M.D. writes more Part D claims than 25% of them and scores higher on MIPS quality than 69% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Allan Fleming, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Allan Fleming, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Allan Fleming, M.D.?
High performer (top quartile)Primary specialty
Medical Oncology Physician
Medicare Part D claims
177 76% vs specialty avg
MIPS final score
91.9/100 8.4 pts vs avg
Specialty distribution in Kansas
How Medical Oncology Physician compares to other specialties among Kansas providers
Medicare quality performance, MIPS
Allan Fleming, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 91.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1730275439 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/04/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.8902
Final Score
Measured-score avg: 83.5
75.1734
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Allan Fleming, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Kansas Hospital Authority
Westwood, KS
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
Allan Fleming, M.D. - brand share 67.0%
Medical Oncology Physician average
67% brand-name claims vs 33% generic, on 177 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
177
Total Claims
$106K
Total Drug Cost
43
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 250.567
- Total Day Supply
- 7,088
- Brand vs Generic
- 67% brand / 33% generic
- Brand Drug Cost
- $86K
- Generic Drug Cost
- $20K
Patient Demographics
- Average Patient Age
- 70.0 years
- Avg HCC Risk Score
- 1.99
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Allan Fleming, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Eliquis
Eliquis
113 claims
- Enoxaparin Sodium 41
Enoxaparin Sodium
41 claims
- Warfarin Sodium 16
Warfarin Sodium
16 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 113 |
| Enoxaparin Sodium | 41 |
| Warfarin Sodium | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Allan Fleming, M.D. fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Allan Fleming, M.D.'s 177 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Fleming, both outside Kansas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.9 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as Fleming.
One of 29 Medical Oncology Physician providers enrolled in Kansas, 5 are shown here.
Dr. Saqib Abbasi
M.D.
Westwood, KS
Dr. Saaib Al Shehadat
MD
Hays, KS
Dr. Joaquina Baranda
MD
Westwood, KS
Dr. Kirstin Binz
MD
Overland Park, KS
Dr. William Cathcart-Rake
M.D.
Salina, KS
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Allan Fleming, M.D.'s specialty? ▼
Allan Fleming, M.D. specializes in Medical Oncology Physician and practices in Kansas City, Kansas. Credentials: M.D..
How much does Allan Fleming, M.D. prescribe under Medicare Part D? ▼
In 2024, Allan Fleming, M.D. wrote 177 Medicare Part D claims totaling $106K in drug costs for 43 beneficiaries.
What is Allan Fleming, M.D.'s Medicare quality score? ▼
Allan Fleming, M.D. has a CMS MIPS Final Score of 91.9/100 (Quality: 75.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Allan Fleming, M.D. located? ▼
Allan Fleming, M.D. is located at 3901 RAINBOW BLVD, Kansas City, KS, 66103. Phone: (913) 588-6029.
What is Allan Fleming, M.D.'s NPI number? ▼
Allan Fleming, M.D.'s National Provider Identifier (NPI) is 1730275439, issued on 10/04/2006.
Does Allan Fleming, M.D. prescribe more brand-name or generic drugs? ▼
Allan Fleming, M.D.'s prescribing is 67% brand-name and 33% generic drugs by claim count, with $86K in brand drug costs.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Allan Fleming, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Allan Fleming, M.D.'s most frequently prescribed drugs include Eliquis, Enoxaparin Sodium, Warfarin Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Allan Fleming, M.D. accept Medicare? ▼
Allan Fleming, M.D. appears in CMS Medicare data with 177 Part D claims and 43 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Allan Fleming, M.D.'s credentials? ▼
Allan Fleming, M.D.'s NPI is 1730275439 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.